These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 9624553
1. Antitumor killer lymphocytes in the peripheral blood of a patient with transitional cell carcinoma of the bladder. Kim CJ, Yuasa T, Kushima R, Tomoyoshi T, Seto A. Int J Urol; 1998 May; 5(3):230-6. PubMed ID: 9624553 [Abstract] [Full Text] [Related]
2. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer. Mizutani Y, Okada Y, Terachi T, Yoshida O. J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600 [Abstract] [Full Text] [Related]
3. Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer. Mizutani Y, Okada Y, Yoshida O, Bonavida B. Cancer Biother Radiopharm; 1996 Dec; 11(6):385-91. PubMed ID: 10851499 [Abstract] [Full Text] [Related]
4. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study. Wilhelm SA, Mukherji B. J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936 [Abstract] [Full Text] [Related]
5. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer. Mizutani Y, Yoshida O. J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797 [Abstract] [Full Text] [Related]
7. Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes. Mizutani Y, Yoshida O, Miki T. J Urol; 1999 Dec; 162(6):2170-5. PubMed ID: 10569614 [Abstract] [Full Text] [Related]
8. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder. Carballido JA, Moltó LM, Manzano L, Olivier C, Salmerón OJ, Alvarez de Mon M. Cancer; 1993 Sep 01; 72(5):1743-8. PubMed ID: 8348503 [Abstract] [Full Text] [Related]
9. In vitro enhancement of natural killer cell activity by BCG and the antagonistic inhibition of the susceptibility of K562 cells to lysis by peripheral blood lymphocytes in patients with urinary bladder tumor. Mizutani Y, Yoshida O. Int J Urol; 1994 Mar 01; 1(1):49-56. PubMed ID: 7627838 [Abstract] [Full Text] [Related]
10. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Santin AD, Bellone S, Ravaggi A, Pecorelli S, Cannon MJ, Parham GP. Obstet Gynecol; 2000 Sep 01; 96(3):422-30. PubMed ID: 10960637 [Abstract] [Full Text] [Related]
11. Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma. Lin CT, Tung CL, Tsai YS, Shen CH, Jou YC, Yu MT, Wu SF. Urol Oncol; 2012 Sep 01; 30(5):680-7. PubMed ID: 21420334 [Abstract] [Full Text] [Related]
12. Prognostic significance of soluble Fas in the serum of patients with bladder cancer. Mizutani Y, Yoshida O, Bonavida B. J Urol; 1998 Aug 01; 160(2):571-6. PubMed ID: 9679930 [Abstract] [Full Text] [Related]
13. Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer. Mizutani Y, Nio Y, Fukumoto M, Yoshida O. Cancer; 1992 Jan 15; 69(2):537-45. PubMed ID: 1728384 [Abstract] [Full Text] [Related]
14. Immunological responses against an autologous human hepatocellular carcinoma cell line. Usuda S, Yoshizawa K, Yabu K, Kiyosawa K. J Gastroenterol Hepatol; 1993 Jan 15; 8(6):517-23. PubMed ID: 8280838 [Abstract] [Full Text] [Related]
15. Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells. Mizutani Y, Nio Y, Yoshida O. J Urol; 1992 Feb 15; 147(2):505-10. PubMed ID: 1732632 [Abstract] [Full Text] [Related]
16. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes. Mizutani Y, Nio Y, Yoshida O. Cancer; 1992 Jun 15; 69(12):2999-3007. PubMed ID: 1591693 [Abstract] [Full Text] [Related]
17. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells. Allavena P, Introna M, Sessa C, Mangioni C, Mantovani A. J Natl Cancer Inst; 1982 Apr 15; 68(4):555-62. PubMed ID: 6175786 [Abstract] [Full Text] [Related]
18. An analysis of autologous T-cell anti-tumour responses in colon-carcinoma patients following active specific immunization (ASI). Patel BT, Lutz MB, Schlag P, Schirrmacher V. Int J Cancer; 1992 Jul 30; 51(6):878-85. PubMed ID: 1639535 [Abstract] [Full Text] [Related]
19. IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response. Guarini A, Gansbacher B, Cronin K, Fierro MT, Foa R. Cytokines Mol Ther; 1995 Mar 30; 1(1):57-64. PubMed ID: 9384664 [Abstract] [Full Text] [Related]